Trials / Completed
CompletedNCT00699556
Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
This study examines the effect of combined nicotine replacement therapy (transdermal patch + nasal spray vs. transdermal patch + placebo nasal spray) on reactivity to alcohol and self-administration behavior.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 21mg transdermal nicotine patch (Nicoderm CQ) | 21mg transdermal nicotine patch |
| DRUG | 1mg nicotine nasal spray | two 0.5mg/sprays, one to each nostril (dose = 1mg) The nicotine nasal spray is formulated by the Investigational Drug Service at Yale-New Haven Hospital. It is similar in concentration to Nicotrol. |
| DRUG | placebo nasal spray | saline combined with capsaicin to mimic the brief nasal irritation from active nicotine spray The placebo nasal spray is formulated by the Investigational Drug Service at Yale-New Haven Hospital. |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2016-11-01
- Completion
- 2016-11-01
- First posted
- 2008-06-18
- Last updated
- 2018-03-12
- Results posted
- 2018-03-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00699556. Inclusion in this directory is not an endorsement.